Key statistics dashboard for Cue Biopharma, Inc. (CUE). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigational therapeutic is CUE-101, a specialized fusion protein biologic.
Stock Data
| Price | $34.17 |
| Market Cap | $90M |
| Enterprise Value | $81.2M |
| Beta | 1.58 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.17 |
| Price / Book | 86.85 |
| P/S | 2.21 |
| EV/EBITDA | -0.85 |
| EV/Sales | 2.16 |
| EV/FCF | -1.62 |
| P/FCF | -1.66 |
| Earnings Yield | -75.74% |
| FCF Yield | -55.87% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 99.69% |
| EBIT Margin | -260.55% |
| EBITDA Margin | -254.67% |
| Operating Margin | -261.97% |
| Net Margin | -435.83% |
| Return on Equity | -1032.19% |
| Return on Assets | -534.43% |
| Return on Invested Capital | -887.33% |
| Return on Capital Employed | -1039.56% |
Financial Health
| Current Ratio | 1.25 |
| Quick Ratio | 1.25 |
| Cash Ratio | 0.82 |
| Debt / Equity | 3.81 |
| Debt / Assets | 28.68% |
| Net Debt / EBITDA | 0.09 |
| Interest Coverage | -730.70 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -11.88 |
Per-Share Data
| Revenue per share | 5.94 |
| Book Value per share | 0.36 |
| Cash per share | 2.74 |
| FCF per share | -7.91 |
| Tangible Book Value per share | 0.36 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 9 |
| Avg rating (1-5) | 1.00 |
Related companies: BRNS · COEP · EQ · IOBT · IPSC · MDCX · NRXP
Explore sector: Healthcare · Biotechnology
More sections of CUE: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks